Yahoo · Sep 4, 2026
Anthropic's IPO Push Just Got a $15 Billion Backstop
The company is reportedly preparing an IPO that could rival or exceed SpaceX's
NYSE · MS
Morgan Stanley
Financial Services · Financial - Capital Markets
$217.15
Down-$0.64 (-0.29%)
Updated Sep 4, 2026, 4:38 PM
SID Score
7.3/10
Composite research score
Smart Money
44/100
Neutral
- Market cap
- 286.34B
- P/E ratio
- 17.5
- Dividend yield
- 1.77%
- 52-week range
- $152.80 – $232.25
- Volume
- 3.87M
- Avg. volume
- 5.7M
Price performance
MS price history
1M range · 21 trading sessions · Daily adjusted prices
MS closed at $217.15 after 21 trading sessions, up 1.59% for the selected period.
- Last close
- $217.15
- Period change
- +1.59%
- Period low
- $207.45
- Period high
- $218.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $213.20 | $217.81 | $213.20 | $217.15 | 3.87M |
| Sep 2, 2026 | $211.97 | $216.15 | $210.60 | $211.82 | 3.62M |
| Sep 1, 2026 | $210.22 | $216.26 | $208.91 | $211.04 | 3.52M |
| Aug 31, 2026 | $214.30 | $214.50 | $212.62 | $213.32 | 4.21M |
| Aug 28, 2026 | $215.40 | $216.65 | $214.19 | $214.77 | 3.74M |
| Aug 27, 2026 | $214.03 | $216.515 | $213.50 | $214.86 | 3.93M |
| Aug 26, 2026 | $217.00 | $217.00 | $211.85 | $214.08 | 4.13M |
| Aug 25, 2026 | $214.86 | $217.34 | $213.365 | $216.77 | 3.27M |
| Aug 24, 2026 | $214.44 | $216.3026 | $213.22 | $214.08 | 3.44M |
| Aug 21, 2026 | $210.08 | $214.57 | $209.1289 | $214.20 | 4.57M |
| Aug 20, 2026 | $214.29 | $215.065 | $207.32 | $207.45 | 4.88M |
| Aug 19, 2026 | $218.775 | $218.775 | $213.555 | $214.23 | 4.91M |
| Aug 18, 2026 | $217.06 | $217.70 | $215.185 | $217.55 | 2.78M |
| Aug 17, 2026 | $217.36 | $220.53 | $217.36 | $218.21 | 3.4M |
| Aug 14, 2026 | $217.795 | $218.715 | $215.3001 | $217.36 | 3.41M |
| Aug 13, 2026 | $219.30 | $222.00 | $217.88 | $218.38 | 3.61M |
| Aug 12, 2026 | $218.49 | $220.50 | $216.98 | $217.64 | 3.74M |
| Aug 11, 2026 | $216.32 | $217.21 | $213.52 | $215.07 | 3.79M |
| Aug 10, 2026 | $216.33 | $217.615 | $214.38 | $215.33 | 3.84M |
| Aug 7, 2026 | $213.74 | $216.47 | $211.8108 | $216.33 | 5.23M |
| Aug 6, 2026 | $219.01 | $219.7765 | $213.54 | $213.75 | 3.59M |
Latest MS news
The latest Smart Investors Daily articles mentioning MS.
Stock researchCompany · Overview
MS research
Overview
Company profile and research snapshot.
Company profile
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $181.00
- Implied upside
- —
- Analysts
- 17
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | UBS | Buy | — |
| Jul 21, 2026 | HSBC | Hold | — |
| Jul 17, 2026 | Evercore ISI Group | Outperform | — |
| Jul 17, 2026 | Citigroup | Neutral | — |
| Jul 17, 2026 | Freedom Broker | Buy | — |
News briefing
Generated Sep 4, 2026, 3:18 PM
Why Is MS Down Today?
Morgan Stanley shares declined 1.12% today despite the firm's active role in hosting major investor conferences and releasing bullish research across multiple sectors. The modest pullback appears disconnected from company-specific negative news, suggesting the decline reflects broader market dynamics rather than fundamental concerns about the investment banking and wealth management giant.
Bottom line: Morgan Stanley's 1.12% decline appears to be a minor pullback in an otherwise solid news environment, with the firm actively engaged in high-value investor conferences and maintaining bullish research on key sectors like semiconductors and healthcare REITs. Investors should monitor upcoming deal flow and trading volumes as indicators of whether the firm can capitalize on its research credibility and conference platforms to drive revenue growth despite mixed macro conditions.
Yahoo · Sep 4, 2026
Allwyn (ATSE:ALWN) Stock Fair Value Edges Lower As Analysts Weigh Margin And Growth Risks
Allwyn’s analyst fair value has been nudged from €14.26 to €14.17, signalling a small trim to where models currently anchor the stock. This sits alongside research coverage that clusters around the mid teens, where analysts balance confidence in cash generation with questions over execution after the OPAP combination and the focus on North America. As you read on, you will see how this latest price target move fits into the evolving analyst story and what to watch next. Stay updated as the...
Yahoo · Sep 4, 2026
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
CHICAGO, September 04, 2026--Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 8:30 a.m. ET in New York City.
Yahoo · Sep 4, 2026
Anthropic looks set to tie up $15bn of pre-IPO funding
Anthropic is close to finalising an expansion of its revolving credit facility to $15 billion, according to people familiar with the matter, clearing a key hurdle before the AI company files publicly for its highly anticipated IPO. Morgan Stanley (NYSE:MS) is leading the process, with Goldman...
AI research layers
Interpretive context generated from the platform’s current data sources.
Morgan Stanley Stock Performance
Morgan Stanley shares trade at $217.15, reflecting a modest 0.51% decline over the past month and an identical 0.51% decline over the trailing three-month period, per SID market data. However, the stock has delivered a strong 23.02% gain over the past twelve months, significantly outpacing the broader market. From a technical perspective, the stock currently sits just above its 50-day moving average of $215.65, suggesting near-term consolidation around current levels. The 200-day moving average stands at $190.35, placing the stock approximately 14.1% above this longer-term trend line, according to Massive/Polygon data. The 14-day relative strength index reads 49.7, indicating neutral momentum with no overbought or oversold conditions. Morgan Stanley carries a beta of 1.215, reflecting moderately higher volatility than the overall market. Average daily trading volume registers at approximately 5.7 million shares, supporting adequate liquidity for institutional participants.
Morgan Stanley Valuation Analysis
Morgan Stanley currently commands a market capitalization of approximately $286.3 billion, positioning it among the largest financial services firms globally, per SID market data. The stock trades at a price-to-earnings ratio of 17.50, which reflects a moderate valuation within the Financial Services sector. The PEG ratio stands at 1.70, according to SEC filings, suggesting the stock is priced at a slight premium relative to its expected earnings growth trajectory. Morgan Stanley's price-to-book ratio of 2.57 indicates the market values the firm at more than two and a half times its book value, a metric that reflects investor confidence in the company's return on equity and franchise value. The company offers a dividend yield of 2.14%, providing a meaningful income component for shareholders. These valuation metrics collectively suggest that Morgan Stanley is trading within a reasonable range relative to its financial sector peers, balancing growth expectations with current profitability levels.
Smart Money Activity for MS
Morgan Stanley's composite smart money score stands at 44 out of 100, registering a neutral overall signal, per SID market data. Institutional positioning is notably strong, scoring a maximum 25 out of 25, indicating robust confidence from large asset managers and fund complexes. In contrast, the insider activity component scores 0 out of 25, reflecting a bearish tilt from corporate executives. According to SEC Form 4 filings, there have been seven insider transactions over the past 90 days, all of which were sales with zero insider purchases recorded during this period. The dark pool activity score is 7.3 out of 25, suggesting relatively subdued off-exchange institutional accumulation. Congressional trading activity scores 12 out of 25, indicating moderate engagement from lawmakers, per 13F institutional filings. The divergence between maximum institutional confidence and persistent insider selling creates a notable contrast within the smart money framework, warranting attention from investors monitoring ownership dynamics at Morgan Stanley.
Morgan Stanley Earnings Outlook
Morgan Stanley has established a consistent pattern of earnings beats across its most recent reported quarters, according to company earnings reports. In the most recent quarter, the company posted earnings per share of $3.46 against an analyst consensus estimate of $2.81, representing a positive surprise of $0.65 or approximately 23.1%. The preceding quarter saw EPS of $3.43 versus estimates of $3.04, delivering a $0.39 upside surprise. Earlier, the company reported EPS of $2.68 compared to the $2.43 estimate, beating expectations by $0.25. Looking ahead, analysts project EPS of $2.95 for the upcoming reporting period, per analyst estimates. The sequential improvement in both absolute earnings and the magnitude of positive surprises suggests strengthening operational execution. Morgan Stanley's ability to consistently exceed Wall Street expectations across multiple quarters demonstrates effective revenue generation and expense management throughout varying market conditions.
Wall Street Analyst Ratings for MS
Recent Wall Street coverage reflects a generally constructive stance on Morgan Stanley, per SID consensus data. On August 3, 2026, UBS reiterated its Buy rating on the stock, maintaining its positive outlook. Evercore ISI Group similarly maintained an Outperform rating on July 17, 2026, reinforcing bullish sentiment among sell-side analysts, according to Wall Street analyst reports. Notably, Freedom Broker upgraded Morgan Stanley from Hold to Buy on July 17, 2026, representing the only directional rating change in the recent coverage period. Meanwhile, Citigroup maintained its Neutral rating on the same date, and HSBC reiterated its Hold rating on July 21, 2026, reflecting a more cautious perspective from these two firms. Across the five most recent analyst actions, three carry Buy or equivalent recommendations while two maintain Hold or Neutral positions. The absence of any Sell ratings and the presence of one upgrade suggest that Wall Street consensus leans constructively toward Morgan Stanley's near-term prospects.
